GB9409387D0 - Glucan-binding domains (gbp's) and hybird proteins containing gbd's as novel active systems targeted to dental plaque - Google Patents

Glucan-binding domains (gbp's) and hybird proteins containing gbd's as novel active systems targeted to dental plaque

Info

Publication number
GB9409387D0
GB9409387D0 GB9409387A GB9409387A GB9409387D0 GB 9409387 D0 GB9409387 D0 GB 9409387D0 GB 9409387 A GB9409387 A GB 9409387A GB 9409387 A GB9409387 A GB 9409387A GB 9409387 D0 GB9409387 D0 GB 9409387D0
Authority
GB
United Kingdom
Prior art keywords
hybird
gbd
gbp
glucan
binding domains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB9409387A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever PLC
Original Assignee
Unilever PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever PLC filed Critical Unilever PLC
Priority to GB9409387A priority Critical patent/GB9409387D0/en
Publication of GB9409387D0 publication Critical patent/GB9409387D0/en
Priority to JP7529437A priority patent/JPH10500127A/en
Priority to EP95918091A priority patent/EP0759081A1/en
Priority to PCT/GB1995/001070 priority patent/WO1995031556A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
    • A61K47/557—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells the modifying agent being biotin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB9409387A 1994-05-11 1994-05-11 Glucan-binding domains (gbp's) and hybird proteins containing gbd's as novel active systems targeted to dental plaque Pending GB9409387D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB9409387A GB9409387D0 (en) 1994-05-11 1994-05-11 Glucan-binding domains (gbp's) and hybird proteins containing gbd's as novel active systems targeted to dental plaque
JP7529437A JPH10500127A (en) 1994-05-11 1995-05-11 Glucan binding protein and use thereof
EP95918091A EP0759081A1 (en) 1994-05-11 1995-05-11 Glucan-binding proteins, and use thereof
PCT/GB1995/001070 WO1995031556A1 (en) 1994-05-11 1995-05-11 Glucan-binding proteins, and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9409387A GB9409387D0 (en) 1994-05-11 1994-05-11 Glucan-binding domains (gbp's) and hybird proteins containing gbd's as novel active systems targeted to dental plaque

Publications (1)

Publication Number Publication Date
GB9409387D0 true GB9409387D0 (en) 1994-06-29

Family

ID=10754939

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9409387A Pending GB9409387D0 (en) 1994-05-11 1994-05-11 Glucan-binding domains (gbp's) and hybird proteins containing gbd's as novel active systems targeted to dental plaque

Country Status (4)

Country Link
EP (1) EP0759081A1 (en)
JP (1) JPH10500127A (en)
GB (1) GB9409387D0 (en)
WO (1) WO1995031556A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9613758D0 (en) † 1996-07-01 1996-09-04 Unilever Plc Detergent composition
AU4616797A (en) 1996-10-25 1998-05-22 Novo Nordisk A/S An oral care product comprising a mutan binding domain
AUPP051497A0 (en) 1997-11-24 1997-12-18 University Of Melbourne, The Antimicrobial peptides
AU7470998A (en) * 1998-05-01 1999-11-23 Procter & Gamble Company, The Laundry detergent and/or fabric care compositions comprising a modified transferase
WO1999057155A1 (en) * 1998-05-01 1999-11-11 The Procter & Gamble Company Laundry detergent and/or fabric care compositions comprising a modified antimicrobial protein
FR2834209B1 (en) * 2001-12-31 2004-04-23 Oreal COSMETIC COMPOSITIONS COMPRISING A COSMETIC ACTIVE AGENT AND AN EXOGENOUS HAIR LIGAND-RECEPTOR SYSTEM AND METHOD FOR TREATING HAIR USING THE SAME
FR2838640B1 (en) * 2002-04-19 2006-02-24 Oreal COSMETIC COMPOSITION COMPRISING A COSMETIC ACTIVE AND A FIXED EXOGENOUS LIGAND-RECEPTOR SYSTEM COMPRISING HAIR COVALENT AND HAIR PROCESSING METHOD USING THE SAME
US7601511B2 (en) 2003-11-12 2009-10-13 University Of Georgia Research Foundation, Inc. Biotin-facilitated transport in gram negative bacteria
NZ548218A (en) 2003-12-19 2009-02-28 Univ Melbourne Antimicrobial composition comprising a casein peptide and a divalent cation useful for treating dental caries
CN105687108A (en) 2008-06-13 2016-06-22 奥洁克公司 Use of hydrogen peroxide-producing bacteria for tooth whitening

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2641228B2 (en) * 1988-01-22 1997-08-13 鐘紡株式会社 Antibody, caries preventive agent containing the same as an active ingredient, and methods for producing the same
US5340731A (en) * 1988-07-08 1994-08-23 University Of British Columbia Method of preparing a B-1,4 glycan matrix containing a bound fusion protein
IL96475A0 (en) * 1989-11-29 1991-08-16 Innovative Tech Center Chimeric proteins
JPH07506374A (en) * 1992-05-01 1995-07-13 フォーシス デンタル インファーマリー フォー チルドレン Synthetic peptide vaccine for caries prevention

Also Published As

Publication number Publication date
JPH10500127A (en) 1998-01-06
WO1995031556A1 (en) 1995-11-23
EP0759081A1 (en) 1997-02-26

Similar Documents

Publication Publication Date Title
PL332547A1 (en) Skin care compositions containing an acid and retinoide
HK1015269A1 (en) Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof
PL322624A1 (en) Skin care composition containing retinoides and liposomes
AU8897298A (en) System and method of noninvasevely determining a patient's susceptibility to arrhythmia
GR3034613T3 (en) Particles based on polyamino-acid(s) for use as carriers for active agents and their processes of preparation
IL114987A0 (en) Modulators of body weight, corresponding nuclic acid and proteins, and diagnostic and therapeutic uses thereof
HUT75089A (en) Compositions containing hyaluronic acid or it's derivatives and pharmaceutical active agent
PL332542A1 (en) Skin care compositions containing amide and retinoide
PL320634A1 (en) Method of purifying and isolating 2'-deoxy - 2', 2' - difluoronucceosides
MX192025B (en) Cosmetic composition, preparation and application of same
PL326932A1 (en) Supported catalyst containing an activator capable to form "captured" cations
HUP9603272A3 (en) An oral composition enhancing brain's activity
PL341058A1 (en) Compositions useful in reducing weight of patient's body
SG43798A1 (en) Agonists and antagonistis of human interleukin-10
US5656608B1 (en) Amino acid compositions and methods of treatment using same
EP0756636A4 (en) Chondroitinases i and ii, methods of preparation, and use thereof
AU8768298A (en) Chemical modification of proteins to improve biocompatibility and bioactivity
GB9409387D0 (en) Glucan-binding domains (gbp's) and hybird proteins containing gbd's as novel active systems targeted to dental plaque
IL114331A0 (en) Medical use of bromelain
PL330178A1 (en) Precipitated silicic acids containing active substance, method of obtaining them and mouth care agent based on such acids
HU9601250D0 (en) Biologically active silicon-compounds and their pharmaceutical and cosmetical use
EP0711156A4 (en) Use of n-methyl-aspartic acid for enhancing growth and altering body composition
GB2323357B (en) Derivatives of 7-deaza-2-deoxy-guanosine-5'-triphosphate, preparation and use thereof
EP0862442A4 (en) Methods for diagnosis and treatment of bloom's syndrome
AU2137595A (en) Use of arylpiperazine derivatives for the treatment of Parkinson's disease and psychosis